Abstract
Tuberculosis was a major cause of morbidity and mortality in the industrialized countries of North America and Europe at the turn of the century, associated mainly with poverty and poor living conditions. Since then, incidence and prevalence of tuberculosis have decreased dramatically with improvement of living conditions. This is in contrast to the present situation in developing countries, where tuberculosis still causes millions of deaths in the prevailing conditions of malnutrition, crowded living conditions and poverty.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aderele WI (1979) Pulmonary tuberculosis in childhood: an analysis of 263 cases seen at Ibadan, Nigeria. Trop Geogr Med 31: 41–51
Aluoch JA (1985) Practical therapeutics — chemotherapy for pulmonary tuberculosis. East Afr Med J 62: 612–620
Bloom BR, Godal T (1983) Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis 5: 765–780
Browne SG (1984) Leprosy. Acta Clinica. Ciba-Geigy, Basel
Daniel TM (1982) Selective primary health care: strategies for control of disease in the developing world. II. Tuberculosis. Rev Infect Dis 4: 1254–1265
Dutt AK, Stead WW (1985) Tuberculosis chemotherapy today. Ann Acad Med Singapore 14: 508–514
East African/British Medical Research Councils (1977) Tuberculosis in Tanzania: a follow-up of a national sampling survey of drug resistance and other factors. Tubercle 58: 55–78
East African/British Medical Research Councils (1978) Third study, first report: controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 118: 39–48
East African/British Medical Research Councils (1979) Tuberculosis in Kenya: follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. Tubercle 60: 125–149
Fine PEM, Maine N, Ponnighaus JM, Clarkson JA, Bliss L (1986) Protective efficacy of BCG against leprosy in northern Malawi. Lancet II: 499–502
Griffiths DL (1980) Tuberculosis of the spine: a review. Adv Tuberc Res 20: 92–110
Havel A, Pattyn SR (1975) Activity of rifampicin on Mycobacterium ulcerans. Ann Soc Belge Méd Trop 55: 105–108
Hong Kong Chest Service/British Medical Research Council (1981) Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet I: 171–174
Hopewell PC, Sanchez-Hermandez M, Baron RB, Ganter B (1984) Operational evaluation of treatment for tuberculosis. Results of a “standard” 12-month regimen in Peru. Am Rev Respir Dis 129: 439–443
Ji BH, Chen JK, Wang CM, Xia GA (1984) Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy. Lepr Rev 55: 283–289
Joint IUAT/WHO study Group (1982) Tuberculosis control. Tech Rep Ser No 671. WHO, Geneva
Kilpatrick ME, Girgis NI, Yassin MW, Abu El Ella AA (1986) Tuberculous meningitis — clinical and laboratory review of 100 patients. J Hyg 96: 231–238
Leowski J (1982) Thioacetazone — a review. Indian J Chest Allied Sci 24: 184–189
Meyers WM (1984) Leprosy. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edition. Saunders, Philadelphia, pp 409–422
Meyers WM, Connor DH, McCullough B, Bourland J, Moris R, Proos L (1974) Distribution of Mycobacterium ulcerans infections in Zaire, including the report of new foci. Ann Soc Belge Méd Trop 54: 147–157
Nkinda SJ, Mulder DW, Styblo K (1984) Developments in the national tuberculosis control programme in Tanzania. Bull IUAT 59: 77–84
Oluwasanmi JO, Solankee TF, Olurin EO, Itayemi SO, Alabi GO, Lucas AO (1976) Mycobacterium ulcerans ( Buruli) skin ulceration in Nigeria. Am J Trop Med Hyg 25: 122–128
Osuntokun BO, Adeuja AOG, Familusi JB (1971) Tuberculous meningitis in Nigerians — a study of 194 patients. Trop Geogr Med 23: 225–231
Pio A (1983) The future of the fight against tuberculosis in the world. Z Erkr Atmungsorgane 161: 96–99
Radhakrishna S (1983) National tuberculosis programme: relative merits of enhancing the operational efficiency of different components of the treatment programme. Indian J Tuberc 30: 3–8
Riley DN (1984) Treatment of leprosy in rural India as seen on a medical student elective. Lepr Rev 55: 397–402
Stanley SJ, Howland C, Stone MM, Sutherland J (1981) BCG vaccination of children against leprosy in Uganda. Final results. J Hyg 87: 233–248
Stott H (1978) The treatment of pulmonary tuberculosis in the developing countries. Trans R Soc Trop Med Hyg 72: 564–569
Styblo K (1983) The Kellersberger memorial lecture, 1982. Tuberculosis and its control: lessons to be learned from past experience, and implications for leprosy control programmes. Ethiop Med J 21: 101–122
Taqi AM, Abdurrahman MB, Ango SS (1982) Childhood tuberculosis as seen at the Ahmadu Bello University Teaching Hispital, Zaria. Niger J Pediatr 9: 99–103
WHO Study Group (1982) Chemotherapy of leprosy for control programmes. Tech Rep Ser No 675. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Enenkel, S., Stille, W. (1988). Mycobacterial Infections. In: Antibiotics in the Tropics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73276-8_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-73276-8_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18683-0
Online ISBN: 978-3-642-73276-8
eBook Packages: Springer Book Archive